Raimondas Siaulys1, Vita Klimasauskiene2, Vinsas Janusonis1, Viktorija Ezerskiene1, Audrius Dulskas3, Narimantas Evaldas Samalavicius4. 1. Klaipeda University Hospital, Liepojos Str. 41, LT-92288 Klaipeda, Lithuania. 2. Klaipeda University Hospital, Liepojos Str. 41, LT-92288 Klaipeda, Lithuania; Faculty of Medicine, Vilnius University, M. K. Ciurlionio Str. 21/27, LT-03101 Vilnius, Lithuania. 3. Faculty of Medicine, Vilnius University, M. K. Ciurlionio Str. 21/27, LT-03101 Vilnius, Lithuania; National Cancer Institute, Santariskiu Str. 1, LT-08660, Vilnius, Lithuania. Electronic address: audrius.dulskas@nvi.lt. 4. Klaipeda University Hospital, Liepojos Str. 41, LT-92288 Klaipeda, Lithuania; Faculty of Medicine, Vilnius University, M. K. Ciurlionio Str. 21/27, LT-03101 Vilnius, Lithuania; Health Research and Innovation Science Center, Faculty of Health Sciences Klaipeda University, Herkaus Manto Street 84 Klaipeda, Lithuania.
Abstract
OBJECTIVE: In this article, we present the first 100 gynaecological robotic surgeries in Klaipeda University Hospital, Klaipeda, Lithuania. STUDY DESIGN: A prospective analysis was performed of 100 women age range 22-82, on average 52 years. Patients underwent various robotic gynaecological operations, 61 (61 %) procedures were robotic total hysterectomy with bilateral salpingo-oophorectomy. RESULTS: Duration of the surgery varied from 30 min to 185 min, on average 99 ± 33 min. Of all 25 (25 %) patients had operations in the past. Most operations (72 %) were performed for benign diseases and 28 % of the patients were operated for various types of gynaecological malignancies. All cancer surgeries were radical (R0). In-hospital stay was on average 4 ± 2.3 days, range 1-14 days. There were six (6%) conversions: one to laparoscopy and five to open. Three (3%) complications occurred during 30 days after surgery, one demanded surgery (Clavien-Dindo II-IIIb). There was no mortality in this patient population. CONCLUSION: Our early experience with different types of robotic gynaecological surgeries allows us to state that Senhance® robotic system is feasible and safe in gynaecology.
OBJECTIVE: In this article, we present the first 100 gynaecological robotic surgeries in Klaipeda University Hospital, Klaipeda, Lithuania. STUDY DESIGN: A prospective analysis was performed of 100 women age range 22-82, on average 52 years. Patients underwent various robotic gynaecological operations, 61 (61 %) procedures were robotic total hysterectomy with bilateral salpingo-oophorectomy. RESULTS: Duration of the surgery varied from 30 min to 185 min, on average 99 ± 33 min. Of all 25 (25 %) patients had operations in the past. Most operations (72 %) were performed for benign diseases and 28 % of the patients were operated for various types of gynaecological malignancies. All cancer surgeries were radical (R0). In-hospital stay was on average 4 ± 2.3 days, range 1-14 days. There were six (6%) conversions: one to laparoscopy and five to open. Three (3%) complications occurred during 30 days after surgery, one demanded surgery (Clavien-Dindo II-IIIb). There was no mortality in this patient population. CONCLUSION: Our early experience with different types of robotic gynaecological surgeries allows us to state that Senhance® robotic system is feasible and safe in gynaecology.